Lipocalin 2 promotes breast cancer progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 10, 2009, Pages 3913-3918

  Yang, Jiang ^a,b   Bielenberg, Diane R ^a,b   Rodig, Scott J ^c   Doiron, Robert ^a,b   Clifton, Matthew C ^d   Kung, Andrew L ^a   Strong, Roland K ^d   Zurakowski, David ^a,b   Moses, Marsha A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Biomarker; Epithelial to mesenchymal transition; Estrogen receptor

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FIBRONECTIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER INVASION; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL TO MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RNA INTERFERENCE; TUMOR XENOGRAFT; URINE;

ACUTE-PHASE PROTEINS; ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE SILENCING; HUMANS; LIPOCALINS; LYMPHATIC METASTASIS; MESODERM; MICE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHENOTYPE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 62649098660     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0810617106     Document Type: Article

References (39)

1. Bratt T (2000) Lipocalins and cancer. Biochim Biophys Acta 1482:318-326.
2. Gruvberger S, et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984.
3. Jones C, et al. (2004) Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. Cancer Res 64:3037-3045.
4. Taylor-Papadimitriou J, Lane EB (1987) in The Mammary Gland, Development, Regulation and Function, eds Neville MC, Daniel CW (Plenum, New York), pp 181-215.
5. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
6. Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118:277-279.
7. Stoesz SP, et al. (1998) Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79:565-572.
8. Seth P, et al. (2002) Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res 62:4540-4544.
9. McDonnell DP, Norris JD (2002) Connections and regulation of the human estrogen receptor. Science 296:1642-1644.
10. Fujita N, et al. (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207-219.
11. Barrallo-Gimeno A, Nieto MA (2005) The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development (Cambridge, UK) 132:3151-3161.
12. Boyer B, Roche S, Denoyelle M, Thiery JP (1997) Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J 16:5904-5913.
13. Takano S, et al. (2007) Smad4 is essential for down-regulation of E-cadherin induced by TGF-β in pancreatic cancer cell line PANC-1. J Biochem (Tokyo) 141:345-351.
14. Brown KA, et al. (2004) Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 6:R215-R231.
15. Lacroix M, Leclercq G (2004) Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat 83:249-289.
16. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT (1997) Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 150:483-495.
17. Haybittle JL, et al. (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361-366.
18. Bauer M, et al. (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 108:389-397.
19. Hajra KM, Chen DY, Fearon ER (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62:1613-1618.
20. Goetz DH, et al. (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10:1033-1043.
21. Yang J, et al. (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10:1045-1056.
22. Devireddy LR, Gazin C, Zhu X, Green MR (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123:1293-1305.
23. Behrens J, Mareel MM, Van Roy FM, Birchmeier W (1989) Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108:2435-2447.
24. Vleminckx K, Vakaet L, Jr, Mareel M, Fiers W, van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119.
25. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial- mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172:973-981.
26. Lim R, et al. (2007) Neutrophil gelatinase-associated lipocalin (NGAL), an early screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 120:2426-2434.
27. Lee HJ, et al. (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer 118:2490-2497.
28. Hanai J, et al. (2005) Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem 280:13641-13647.
29. Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW, Schutte M (2007) Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res 5:195-201.
30. Devireddy LR, Teodoro JG, Richard FA, Green MR (2001) Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293:829-834.
31. Liu Q, Nilsen-Hamilton M (1995) Identification of a new acute phase protein. J Biol Chem 270:22565-22570.
32. Klausen P, Niemann CU, Cowland JB, Krabbe K, Borregaard N (2005) On mouse and man: Neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur J Haematol 75:332-340.
33. Moses MA, et al. (1998) Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 58:1395-1399.
34. Yan L, Borregaard N, Kjeldsen L, Moses MA (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL): Modulation of MMP-9 activity by NGAL. J Biol Chem 276:37258-37265.
35. Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA (2004) ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 279:51323-51330.
36. Armstrong SA, et al. (2003) Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 3:173-183.
37. Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50:717-721.
38. Fernandez CA, et al. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11:5390-5395.
39. Bland M (2000) An Introduction to Medical Statistics (Oxford Univ Press, Oxford, UK).